Prevention of Gynecologic Malignancies
David S. Alberts(University of Arizona), Joan L. Walker(Cornell University), George L. Mutter(Brigham and Women's Hospital), Gustavo C. Rodriguez(NorthShore University HealthSystem), Michael Method(ImmunoGen (United States)), Mark G. Hanly(Gynecologic Oncology Group), Lori M. Minasian(National Cancer Institute), Joseph A. Lucci(University of Miami), John F. Boggess(University of Kentucky), Joseph Kelaghan(University of North Carolina at Chapel Hill), Zoreh Davanipour(University of Southern California), Louise A. Brinton(National Cancer Institute), Mary B. Daly(Fox Chase Cancer Center), Francisco García(University of Arizona), Doris M. Benbrook(Oklahoma State University Oklahoma City), Richard R. Barakat(Cornell University), Philip E. Castle(National Cancer Institute), Eugene Sobel(University of Southern California), Carolyn Y. Muller(University of New Mexico), Molly Brewer(UConn Health), Janet S. Rader(Medical College of Wisconsin), Jeffrey F. Hines, Lisa M. Hess(University of Arizona)
Cited by 3
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k